Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Sleep Physicians (US)

Warren Botnick, MD, President
PSS Clinical Research
Analysis of: Newly Discovered Fatty Acids May Lead To Novel Treatments For COPD And Asthma (www.medicalnewstoday.com)
Eicosanoids appear promising in the treatment of such airways diseases as COPD and asthma, which affect millions worldwide.  Any alternative to current anti-inflammatory therapy, which consists almost entirely of forms of corticosteroids, would almost certainly be welcomed and adopted in widespread...
Warren Botnick, MD, President
PSS Clinical Research
Analysis of: Basilea Announces Positive Top-line Data from Phase III Study of Ceftobiprole in Community-acquired Pneumonia Requiring Hospitalization (www.pipelinereview.com)
Cephalosporins have been standard therapy for pneumonia for many years, but to date this class of drug has been ineffective against MRSA.  Ceftobiprole appears to represent a breakthrough in this regard.  I would expect the drug to be well tolerated and, for the most part, to cause few major...
Warren Botnick, MD, President
PSS Clinical Research
Analysis of: GlaxoSmithKline and Sepracor Inc. announce international alliance for commercilisation of Lunivia (www.pipelinereview.com)
Though the potential international market for eszopiclone is large, interest in the product among sleep specialists in the US has leveled off.  Its success internationally may well depend more on distancing the product from other agents such as the Ambien "family," a decidedly difficult task, and...
Warren Botnick, MD, President
PSS Clinical Research
Analysis of: Dabigatran Etexilate As Effective As Enoxaparin In Lowering Blood Clot Risk After Hip Replacement (www.medicalnewstoday.com)
These data help strengthen the growing perception that oral agents in general, direct thrombin inhibitors in particular, and perhaps specifically dabigatran, represent the future of anticoagulation therapy.  Safety data are of paramount importance, given the prior failure of ximelagatran in this...
Warren Botnick, MD, President
PSS Clinical Research
Analysis of: ThromboGenics and BioInvent Announce Successful Completion of Phase I Clinical Trial of the Anticoagulant TB-402 (www.pipelinereview.com)
Phase I data are promising for prevention on VTE, a major worldwide health problem.  However, inhibition of factor VIII raises grave safey concerns, despite safety profile in this study.  Long duration of action and cost also will be important considerations (current drug costs for this indication can...
September 7, 2007
Kudos to the FDA!
Analysis of: FDA Issues Warning Letter To Melanocorp, Inc. For Illegal Sale Of Melanotan II -Agency Warns Consumers About Using And Purchasing Unapproved Product (www.medicalnewstoday.com)
The web based marketing of cyber snake oil is of concern to practitioners of medicine in every venue. Although there are many products have failed to pass sucessfully through the FDA process, this compound among others hallmarks a federal agency's ability to prevent sale of a possible useless or dangerous...
Analysis of: FDA Approves AstraZeneca's Seroquel® For Bipolar Depression Treatment (www.medicalnewstoday.com)
Bipolar depression is a significant problem. It is difficult is treat. Lack of good treatment options at present.
Analysis of: CHEST: Statins May Retard Lung Deterioration in Smokers (www.medpagetoday.com)
1. Statins are an unusual class of pharmaceutics that have a wide range of action beyond lipid management2. Almost all current smokers place themselves at risk for coronary artery disease and have a high prevalence of hyperlipidemia3. Physicians will not likely prescribe statins for lung remodeling
Analysis of: Northfield Laboratories, Inc. Reports First Quarter Fiscal 2007 Financial Results (phx.corporate-ir.net)
1. This product could very well revolutionize the delivery of oxygen to the plethora of organ systems under duress in both perioperative periods as well as in critically ill individuals.2. Decisions to delay blood transfusion for fear of transfusion reaction could probably be laid to rest as long...
Analysis of: Aricept (donepezil) Wins Indication for Severe Alzheimer's (www.medpagetoday.com)
It is long waited decision. I have been using donepezil for last 4 to 5 years in moderate to severe Alzheimer's disease with good results. Only, I did not have statistical data.

Page : 11 to 10 of 10

Analytics


Generated at 2009-01-09T13:00:20.343